PP2A alpha/beta Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30777
Key Product Details
Species Reactivity
Human, Mouse, Rat, Bovine
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen used to generate the purified antibody was a peptide conjugated to KLH corresponding to the sequence NH2-Val-Ser-Ser-Pro-His-Phe-Gln-Val-Ala-GluArg-Ala-Leu-Tyr-COOH.
Specificity
This antibody is specific to pp2A/B isoforms.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for PP2A alpha/beta Antibody
Western Blot: PP2A alpha/beta Antibody [NBP3-30777] -
Western Blot: PP2A alpha/beta Antibody [NBP3-30777] - Legend: Novus Biologicals PP 2 A/B’ pan 2 antibody western blot of total rat brain extract.(+) indicates blocking specific peptide or (-) or control peptide added.Applications for PP2A alpha/beta Antibody
Application
Recommended Usage
Western Blot
: 1:500-1:1000
Application Notes
.
Formulation, Preparation, and Storage
Purification
Ammonium sulfate precipitation
Formulation
Phosphate buffered saline
Preservative
0.08% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: PP2A alpha/beta
Alternate Names
PPP2CA, PPP2CB, Replication protein C, RP-C, serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform, serine/threonine-protein phosphatase 2A catalytic subunit beta isoform
Gene Symbol
PPP2CA
Additional PP2A alpha/beta Products
Product Specific Notices for PP2A alpha/beta Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...